Literature DB >> 446390

Evidence for a role of splanchnic somatostatin in the homeostasis of ingested nutrients.

V Schusdziarra, V Harris, A Arimura, R H Unger.   

Abstract

Somatostatin was infused via the portal vein at a rate of 50 ng/min in a group of eight conscious dogs beginning 30 min before and continuing for 6 h after the ingestion of an 800-g fat-protein meal. The fasting and postprandial levels of plasma somatostatin-like immunoreactivity (SLI), insulin, glucagon, and triglycerides were compared with those during an intraportal infusion of saline as a control. In both groups, SLI rose significantly within 15 min of the ingestion of the meal, but during somatostatin infusion, mean peripheral vein levels of SLI ranged from 30-85 pg/ml above those of the saline control experiments. The postprandial rise in plasma triglycerides was reduced significantly below the control values at all points between 75-270 min, and this reduction was the result of lowered chylomicron levels. Neither fasting nor postprandial insulin or glucagon levels were significantly reduced by the somatostatin infusion. Intraportally infused somatostain also reduced portal vein xylose levels after an intragastric xylose load. The results are compatible with, but do not prove, a physiological role for somatostatin in the homeostasis of ingested nutrients.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 446390     DOI: 10.1210/endo-104-6-1705

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  18 in total

Review 1.  Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications.

Authors:  D Fleisher; C Li; Y Zhou; L H Pao; A Karim
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

2.  Immunocytochemical localization of muscarinic acetylcholine receptors in the rat endocrine pancreas.

Authors:  E A Van der Zee; B Buwalda; J H Strubbe; A D Strosberg; P G Luiten
Journal:  Cell Tissue Res       Date:  1992-07       Impact factor: 5.249

3.  Effect of rioprostil, a methylprostaglandin E1 analog, on basal and stimulated plasma pancreatic hormone levels in man.

Authors:  O Segers; G Somers
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

4.  Effects of somatostatin added to insulin in a glucose-controlled insulin infusion system.

Authors:  J L Selam; D Chenon; T C Pham; J P Gagnol; C Sany; N Thomas; G Gravagne; A Orsetti; J Mirouze
Journal:  Diabetologia       Date:  1981-08       Impact factor: 10.122

5.  Evidence for a role of free fatty acids in the regulation of somatostatin secretion in normal and alloxan diabetic dogs.

Authors:  T Wasada; B Howard; R E Dobbs; R H Unger
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

6.  Release of somatostatin-like immunoreactivity from incubated rat hypothalamus and cerebral cortex. Effects of glucose and glucoregulatory hormones.

Authors:  M Berelowitz; D Dudlak; L A Frohman
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

7.  Somatostatin and the intestinal transport of glucose and other nutrients in the anaesthetised rat.

Authors:  C Daumerie; J C Henquin
Journal:  Gut       Date:  1982-02       Impact factor: 23.059

8.  Previous exposure to glucose enhances somatostatin secretion from the isolated perfused rat pancreas.

Authors:  V Grill; M Rundfeldt; S Efendić
Journal:  Diabetologia       Date:  1981-04       Impact factor: 10.122

9.  Pancreatic immunoreactive somatostatin and diabetes mellitus.

Authors:  A Ertan; A Arimura; K Akdamar; T Shibata; K Groot; M Luciano; F J Mather; H Degertekin; N Agrawal; J Ryan
Journal:  Dig Dis Sci       Date:  1984-07       Impact factor: 3.199

10.  Effect of caerulein administration on portal plasma somatostatin in dogs.

Authors:  J Kasanuki; S Fujimoto; H Makino; A Kanatsuka; T Imaizumi; H Koseki; R Kaneko; Y Tokumasa; S Yoshida
Journal:  Gastroenterol Jpn       Date:  1984-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.